Stock Catalyst AI
?? VIP Login VIP €10

Ticker archive · $BMY

$BMY Filing Signals & Market Reactions

Delayed, SEO-crawlable recaps of AI-scored catalysts for $BMY — including observed post-filing price moves. Live streaming stays exclusive to VIP.

? All delayed signals

$BMY

$BMY – Bristol Myers Q3 Beats on Revenue and EPS, Lowers FY Adjusted EPS Guidance

· TELEGRAM · All $BMY
?? Negative AI Sentiment (-1.5 / 10)
  • Q3 revenue of $13.07B beats estimate of $12.71B; Adj. EPS of $1.35 beats estimate of $1.12.
  • FY revenue outlook raised to $49.75B–$50.25B (vs prior ~$49B–$50B).
  • Full-year Adj. EPS guidance cut to $6.35–$6.55 from prior range of $6.75–$7.00.
Observed market reaction after signal
4h -0.50%
Unlock Live VIP Terminal & Telegram – €10/mo Original filing ?
$BMY

$BMY – Bristol Myers Beats Q3 Estimates but Lowers FY Adjusted EPS Guidance

· TELEGRAM · All $BMY
?? Negative AI Sentiment (-2.5 / 10)
  • Q3 revenue of $13.07B beat estimates of $12.71B; adj. EPS of $1.35 beat $1.12 est.
  • Full-year revenue outlook raised slightly to $49.75B–$50.25B (prior $49B–$50B).
  • Full-year adj. EPS guidance cut to $6.35–$6.55 from previously $6.75–$7.00.
Observed market reaction after signal
4h -0.60%
Unlock Live VIP Terminal & Telegram – €10/mo Original filing ?
$BMY

$BMY – BRISTOL-MYERS SQUIBB COMPANY SAYS CORR 40.5% FOR IZA-BREN VS 20.2% FOR CHEMOTHERAPY; MDOR 6.9 VS 4.2 MONTHS; IZA-BREN REDUCES RISK OF PROGRESSION OR DEATH BY 59% IN PHASE 3 BREAST…

· TELEGRAM · All $BMY
?? Positive AI Sentiment (+6.5 / 10)
  • BRISTOL-MYERS SQUIBB COMPANY SAYS CORR 40.5% FOR IZA-BREN VS 20.2% FOR CHEMOTHERAPY; MDOR 6.9 VS 4.2 MONTHS; IZA-BREN REDUCES RISK OF PROGRESSION OR DEATH BY 59% IN PHASE 3 BREAST CANCER STUDY ...
Observed market reaction after signal
4h -1.93% · 24h -2.41%
Unlock Live VIP Terminal & Telegram – €10/mo Original filing ?